1. Home
  2. KLTOW vs THCH Comparison

KLTOW vs THCH Comparison

Compare KLTOW & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • THCH
  • Stock Information
  • Founded
  • KLTOW N/A
  • THCH 2018
  • Country
  • KLTOW United States
  • THCH China
  • Employees
  • KLTOW 3
  • THCH N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • THCH Blank Checks
  • Sector
  • KLTOW Health Care
  • THCH Finance
  • Exchange
  • KLTOW Nasdaq
  • THCH Nasdaq
  • Market Cap
  • KLTOW N/A
  • THCH 84.8M
  • IPO Year
  • KLTOW 2022
  • THCH N/A
  • Fundamental
  • Price
  • KLTOW $0.25
  • THCH $2.93
  • Analyst Decision
  • KLTOW
  • THCH
  • Analyst Count
  • KLTOW 0
  • THCH 0
  • Target Price
  • KLTOW N/A
  • THCH N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • THCH 14.8K
  • Earning Date
  • KLTOW N/A
  • THCH 08-28-2025
  • Dividend Yield
  • KLTOW N/A
  • THCH N/A
  • EPS Growth
  • KLTOW N/A
  • THCH N/A
  • EPS
  • KLTOW N/A
  • THCH N/A
  • Revenue
  • KLTOW N/A
  • THCH $187,384,526.00
  • Revenue This Year
  • KLTOW N/A
  • THCH N/A
  • Revenue Next Year
  • KLTOW N/A
  • THCH N/A
  • P/E Ratio
  • KLTOW N/A
  • THCH N/A
  • Revenue Growth
  • KLTOW N/A
  • THCH N/A
  • 52 Week Low
  • KLTOW N/A
  • THCH $2.15
  • 52 Week High
  • KLTOW N/A
  • THCH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • THCH 57.29
  • Support Level
  • KLTOW N/A
  • THCH $2.75
  • Resistance Level
  • KLTOW N/A
  • THCH $2.99
  • Average True Range (ATR)
  • KLTOW 0.00
  • THCH 0.14
  • MACD
  • KLTOW 0.00
  • THCH 0.02
  • Stochastic Oscillator
  • KLTOW 0.00
  • THCH 86.05

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About THCH TH International Limited Ordinary shares

TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.

Share on Social Networks: